Developing a treatment for elevated levels of low-density lipoprotein cholesterol.
Industry: Health Care
First Day Return: +3.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/14/2013 |
Offer Price | $14.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/25/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Plymouth, MI, United States |
Founded | 1998 |
Employees at IPO | 13 |
Website www.esperion.com |